The Center of Research Excellence in Natural Products Neuroscience (CORE-NPN) at The University of Mississippi School of Pharmacy (UM), initiated four years ago through a COBRE grant, has developed a multidisciplinary team committed to evaluating the effects of natural products on the central nervous system (CNS). The Center now has the potential to develop and sustain an innovative and independently funded research center focused on treating disorders associated with the nervous system. Faculty in the Center and its academic home, the School of Pharmacy, have already reported groundbreaking observations on the roles of cannabinoids and non-cannabinoids in the etiology of weight control, the control of the immune system, treatment of cancer, control of nausea and vomiting in patients receiving anti-neoplastic treatment, glaucoma, and the development of sigma receptor agonists in the treatment of cocaine and methamphetamine abuse. Also, CORE-NPN-supported investigators have increased their competitiveness by attracting extramural funds and publishing in leading journals of neuroscience. The Center will continue to provide an excellent environment for junior and mid-level investigators by working in close collaboration with leading national centers and scientists studying natural products to carry out the proposed projects that build on these novel insights into the pathophysiology of nervous system disorders. To achieve the goal of establishing an innovative and multidisciplinary Center focused on the use of natural products to manage neuropharmacologic disorders, the following Specific Aims are proposed:
Aim 1 is to enhance the competitive independent research funding of four investigators, as detailed in their research proposals. In addition, external and internal renowned scientists in natural products neuroscience will continue to mentor all Center faculty members in basic and clinical neuroscience.
Aim 2 is to sponsor a competitive small grant program that advances research in neuroscience related to the themes outlined in the proposal.
Aim 3 is to continue the expansion of research resources for the development of innovative natural product neuropharmacology - related projects. Core facilities to accomplish this will include: a) acquisition of novel plants and fungi and isolation of biologically active natural products, b) chemical elucidation of the biologically active secondary metabolites and synthesis of derivatives, c) in vitro assays to identify biologically active natural products, and d) in vivo assays to evaluate behavioral studies of the biologically active natural products.
Aim 4 is to continue faculty development and growth of new neuroscience investigators through training in cutting-edge technologies and to promote research opportunities in neuroscience for undergraduate and graduate students being mentored by Center faculty.

Public Health Relevance

The focus on natural products in neuroscience and projects examining integrated models, along with outstanding Center faculty, training opportunities, a small grant program and generous support by the UM administration will ensure the continued growth of a research center that is innovative, multidisciplinary, and moving strongly toward independent funding, along with the development of a core of new and senior neuroscience faculty.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
5P20GM104932-07
Application #
8550120
Study Section
Special Emphasis Panel (ZRR1-RI-B (01))
Program Officer
Liu, Yanping
Project Start
2006-09-04
Project End
2017-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
7
Fiscal Year
2013
Total Cost
$2,026,026
Indirect Cost
$603,852
Name
University of Mississippi
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
067713560
City
University
State
MS
Country
United States
Zip Code
38677
Slater, Shuneize; Lasonkar, Pradeep B; Haider, Saqlain et al. (2018) One-step, stereoselective synthesis of octahydrochromanes via the Prins reaction and their cannabinoid activities. Tetrahedron Lett 59:807-810
Mendonsa, Nicole S; Murthy, S Narasimha; Hashemnejad, Seyed Meysam et al. (2018) Development of poloxamer gel formulations via hot-melt extrusion technology. Int J Pharm 537:122-131
Tarawneh, Amer H; Al-Momani, Lo Ay A; León, Francisco et al. (2018) Evaluation of Triazole and Isoxazole Derivatives as Potential Anti-infective Agents. Med Chem Res 27:1269-1275
Bookwala, Mustafa; Thipsay, Priyanka; Ross, Samir et al. (2018) Preparation of a crystalline salt of indomethacin and tromethamine by hot melt extrusion technology. Eur J Pharm Biopharm 131:109-119
Kallakunta, Venkata Raman; Tiwari, Roshan; Sarabu, Sandeep et al. (2018) Effect of formulation and process variables on lipid based sustained release tablets via continuous twin screw granulation: A comparative study. Eur J Pharm Sci 121:126-138
Dumpa, Nagi Reddy; Sarabu, Sandeep; Bandari, Suresh et al. (2018) Chronotherapeutic Drug Delivery of Ketoprofen and Ibuprofen for Improved Treatment of Early Morning Stiffness in Arthritis Using Hot-Melt Extrusion Technology. AAPS PharmSciTech 19:2700-2709
Gao, Ying; Yin, Junfeng; Rankin, Gary O et al. (2018) Kaempferol Induces G2/M Cell Cycle Arrest via Checkpoint Kinase 2 and Promotes Apoptosis via Death Receptors in Human Ovarian Carcinoma A2780/CP70 Cells. Molecules 23:
Nguyen, Alex L; Khatri, Hari R; Woods, James R et al. (2018) Magnesium-Promoted Additions of Difluoroenolates to Unactivated Imines. J Org Chem 83:3109-3118
Afolayan, Michael; Srivedavyasasri, Radhakrishnan; Asekun, Olayinka T et al. (2018) Chemical and biological studies on Bridelia ferruginea grown in Nigeria. Nat Prod Res :1-5
Friedman, Jamie R; Nolan, Nicholas A; Brown, Kathleen C et al. (2018) Anticancer Activity of Natural and Synthetic Capsaicin Analogs. J Pharmacol Exp Ther 364:462-473

Showing the most recent 10 out of 139 publications